AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration
AbCellera and Empirico Inc. announced that they have entered into a strategic multi-target discovery collaboration. Through each company’s proprietary technologies, the multi-target…
Read More...
Read More...
